Three-Year Follow-up of Radioiodine Therapy for Goitre
Long-Term Follow-up and Outcome of Administering Recombinant Human Thyrotropin as an Adjuvant of Therapy With Radioiodine in the Outpatient Treatment of Multinodular Goitres
Sponsor: Fundação de Amparo à Pesquisa do Estado de São Paulo
Listed as NCT00509483, this NA trial focuses on Tratment of Multinodular Goitre and remains completed. Sponsored by Fundação de Amparo à Pesquisa do Estado de São Paulo, it has been updated 6 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jan 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- University of Sao Paulo
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.